001     148372
005     20240229112702.0
024 7 _ |a 10.1016/S1470-2045(19)30669-2
|2 doi
024 7 _ |a pmid:31797797
|2 pmid
024 7 _ |a 1470-2045
|2 ISSN
024 7 _ |a 1474-5488
|2 ISSN
024 7 _ |a altmetric:71697760
|2 altmetric
037 _ _ |a DKFZ-2019-02928
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Franceschi, Enrico
|b 0
245 _ _ |a EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma.
260 _ _ |a London
|c 2019
|b The Lancet Publ. Group
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1575894207_21053
|2 PUB:(DE-HGF)
|x Review Article
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The European Association of Neuro-Oncology (EANO) and EUropean RAre CANcer (EURACAN) guideline provides recommendations for the diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma. The guideline is based on the 2016 WHO classification of tumours of the CNS and on scientific developments published since 1980. It aims to provide direction for diagnostic and management decisions, and for limiting unnecessary treatments and cost. In view of the scarcity of data in adults with medulloblastoma, we base our recommendations on adult data when possible, but also include recommendations derived from paediatric data if justified. Our recommendations are a resource for professionals involved in the management of post-pubertal and adult patients with medulloblastoma, for patients and caregivers, and for health-care providers in Europe. The implementation of this guideline requires multidisciplinary structures of care, and defined processes of diagnosis and treatment.
536 _ _ |a 312 - Functional and structural genomics (POF3-312)
|0 G:(DE-HGF)POF3-312
|c POF3-312
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Hofer, Silvia
|b 1
700 1 _ |a Brandes, Alba A
|b 2
700 1 _ |a Frappaz, Didier
|b 3
700 1 _ |a Kortmann, Rolf-Dieter
|b 4
700 1 _ |a Bromberg, Jacoline
|b 5
700 1 _ |a Dangouloff-Ros, Volodia
|b 6
700 1 _ |a Boddaert, Nathalie
|b 7
700 1 _ |a Hattingen, Elke
|b 8
700 1 _ |a Wiestler, Benedikt
|b 9
700 1 _ |a Clifford, Steven C
|b 10
700 1 _ |a Figarella-Branger, Dominique
|b 11
700 1 _ |a Giangaspero, Felice
|b 12
700 1 _ |a Haberler, Christine
|b 13
700 1 _ |a Pietsch, Torsten
|b 14
700 1 _ |a Pajtler, Kristian W
|0 P:(DE-He78)a7c1bbac024fa232d9c6b78443328d9d
|b 15
|u dkfz
700 1 _ |a Pfister, Stefan M
|0 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9
|b 16
|u dkfz
700 1 _ |a Guzman, Raphael
|b 17
700 1 _ |a Stummer, Walter
|b 18
700 1 _ |a Combs, Stephanie E
|b 19
700 1 _ |a Seidel, Clemens
|b 20
700 1 _ |a Beier, Dagmar
|b 21
700 1 _ |a McCabe, Martin G
|b 22
700 1 _ |a Grotzer, Michael
|b 23
700 1 _ |a Laigle-Donadey, Florence
|b 24
700 1 _ |a Stücklin, Ana S Guerreiro
|b 25
700 1 _ |a Idbaih, Ahmed
|b 26
700 1 _ |a Preusser, Matthias
|b 27
700 1 _ |a van den Bent, Martin
|b 28
700 1 _ |a Weller, Michael
|b 29
700 1 _ |a Hau, Peter
|b 30
773 _ _ |a 10.1016/S1470-2045(19)30669-2
|g Vol. 20, no. 12, p. e715 - e728
|0 PERI:(DE-600)2035574-9
|n 12
|p e715 - e728
|t The lancet / Oncology Oncology
|v 20
|y 2019
|x 1470-2045
909 C O |o oai:inrepo02.dkfz.de:148372
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 15
|6 P:(DE-He78)a7c1bbac024fa232d9c6b78443328d9d
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 16
|6 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-312
|2 G:(DE-HGF)POF3-300
|v Functional and structural genomics
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2019
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b LANCET ONCOL : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a IF >= 30
|0 StatID:(DE-HGF)9930
|2 StatID
|b LANCET ONCOL : 2017
920 1 _ |0 I:(DE-He78)B062-20160331
|k B062
|l Pädiatrische Neuroonkologie
|x 0
920 1 _ |0 I:(DE-He78)L101-20160331
|k L101
|l DKTK Heidelberg
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)B062-20160331
980 _ _ |a I:(DE-He78)L101-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21